Clinical Trials Directory

Trials / Conditions / Metastatic Adenocarcinoma of the Pancreas

Metastatic Adenocarcinoma of the Pancreas

8 registered clinical trials studyying Metastatic Adenocarcinoma of the Pancreas — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of B
NCT06867497
Boryung Pharmaceutical Co., LtdPhase 1
Active Not RecruitingPhase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Partici
NCT06225999
Institut de Recherches Internationales ServierPhase 2
UnknownMinnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas
NCT05557851
Minneamrita Therapeutics LLCPhase 1
CompletedA Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plu
NCT04083235
IpsenPhase 3
UnknownStudy of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the P
NCT02739633
Samyang Biopharmaceuticals CorporationPhase 2
CompletedOlaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chem
NCT02184195
AstraZenecaPhase 3
TerminatedSafety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC)
NCT01654861
Eastern Regional Medical CenterPhase 1
CompletedTrial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients
NCT00873353
Grupo Gallego de Investigaciones OncologicasPhase 2